Optimization of xanthones for antimalarial activity: the 3,6-bis-omega-diethylaminoalkoxyxanthone series. - Wikidata - awgldk - TriplyDB

Optimization of xanthones for antimalarial activity: the 3,6-bis-omega-diethylaminoalkoxyxanthone series.

Optimization of xanthones for antimalarial activity: the 3,6-bis-omega-diethylaminoalkoxyxanthone series.

http://www.wikidata.org/entity/Q39650901

about

Hemozoin and antimalarial drug discovery Resonance Raman spectroscopy in malaria research.Biological activities of nitidine, a potential anti-malarial lead compound Selective killing of the human malaria parasite Plasmodium falciparum by a benzylthiazolium dye.Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.Identification and SAR Evaluation of Hemozoin-Inhibiting Benzamides Active against Plasmodium falciparum.Molecular and physiologic basis of quinoline drug resistance in Plasmodium falciparum malaria Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening.In-vivo antimalarial activity of some oxygenated xanthones.Leishmanicidal and cholinesterase inhibiting activities of phenolic compounds from Allanblackia monticola and Symphonia globulifera.

P2860

Q28828253-D4FBA6C5-C83C-4416-A884-1D9530ADE34D Q33262368-C681B417-6CC7-408F-911F-4FC483A2A571 Q35885688-80E75765-B83C-4484-A968-8CFA4D64B5BA Q35972511-00E936B3-8D76-4A24-862A-C2C22028F41E Q36295369-6E94409E-6262-41D0-9AAB-F69413C1BBF7 Q37095658-E7EB07A7-5EBE-41FD-8FED-6E9344BB73AD Q37299770-2FFA1231-CB0D-4255-B9E3-8419A0B63CD8 Q40815903-17DE2D41-527C-491A-83D8-8263A81A914B Q44652871-A6A3CA70-4CBE-4F88-B5D7-5BA16C16A95F Q46506487-ED6F1391-DB1A-4170-85FF-BEB5AA519FFD

P2860

Optimization of xanthones for antimalarial activity: the 3,6-bis-omega-diethylaminoalkoxyxanthone series.

http://www.wikidata.org/entity/Q39650901

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Optimization of xanthones for ...... hylaminoalkoxyxanthone series.

@en

Optimization of xanthones for ...... hylaminoalkoxyxanthone series.

@nl

type

label

Optimization of xanthones for ...... hylaminoalkoxyxanthone series.

@en

Optimization of xanthones for ...... hylaminoalkoxyxanthone series.

@nl

prefLabel

Optimization of xanthones for ...... hylaminoalkoxyxanthone series.

@en

Optimization of xanthones for ...... hylaminoalkoxyxanthone series.

@nl

P1433

Q39650901-5E927C2E-56C0-4697-B92C-0663FE706077

P1476

Q39650901-C5ED1B36-6343-47A7-A8C0-3C56583BFFD5

P2093

Q39650901-22F81C03-8695-4575-99CF-F08953CF9F0E

Q39650901-6808EDDF-01D1-4B48-BB90-647CB672DF29

Q39650901-8F76244C-DF44-4E22-8023-FB299CB47E06

Q39650901-A16CC9D6-92E7-43A5-BD7C-9D3EB430A946

Q39650901-BF59E644-86A9-44E3-8FE5-E9E6D425D443

P2860

Q39650901-20F4B268-B5EF-450B-A9AF-9EB5C92F97F1

Q39650901-246ED30F-08F2-4DB5-81F4-3D7046531A6E

Q39650901-30B62CAC-2E4C-42C4-8220-027D6AD95EBE

Q39650901-3C4B29D3-85EB-48A9-97C6-BEC5059F972A

Q39650901-4523822A-8094-49D3-A414-5D83A50B011C

Q39650901-47C4CA5F-2900-4305-88AA-23D11AB8A5FD

Q39650901-4D630798-1F63-4874-A5A2-992A196FAAF9

Q39650901-5B2F5AD2-6229-46BA-9B1E-7C91CDDA0C49

Q39650901-6253E0AB-A014-4F95-9588-89B014D54913

Q39650901-65472F9B-F450-4B1F-BFB6-3CA162CB0FB2

P304

Q39650901-02F24FCE-0ECC-4C52-88C9-B9A5219990D8

P31

Q39650901-9440D333-2800-4AC9-8FA6-22EDD1C16361

P356

Q39650901-DF618A83-CD64-423F-95B3-6913D1476F0B

P407

Q39650901-2B042F92-EEAF-4F68-A029-C8C151636AE5

P433

Q39650901-660ACB3F-B01D-4CDE-8CA2-1675CF3B5017

P478

Q39650901-28DF8353-3BA5-4A1F-AC95-340F75896719

P577

Q39650901-AE8FDCFC-D7A1-44E6-B2D6-3A93D16A8823

P698

Q39650901-E0891513-9150-4845-B42D-D2F4C999CBEA

P921

Q39650901-049C64CD-5508-4FC5-9C43-145ED7EEA126

P932

Q39650901-AE5411B3-16A2-4701-9596-35AA943BD8DD

P356

AAC.46.1.144-150.2002

P1433

Antimicrobial Agents and Chemotherapy

P1476

Optimization of xanthones for ...... hylaminoalkoxyxanthone series.

@en

P2093

David H Peyton

http://www.w3.org/2001/XMLSchema#string

David J Hinrichs

http://www.w3.org/2001/XMLSchema#string

Jane Xu Kelly

http://www.w3.org/2001/XMLSchema#string

Michael Riscoe

http://www.w3.org/2001/XMLSchema#string

Rolf Winter

http://www.w3.org/2001/XMLSchema#string

P2860

Hemoglobin metabolism in the malaria parasite Plasmodium falciparum

Human malaria parasites in continuous culture

The plasmodium digestive vacuole: metabolic headquarters and choice drug target.

Proteases of protozoan parasites.

The structure of malaria pigment beta-haematin.

Chloroquine-resistant malaria.

Mode of action and mechanisms of resistance for antimalarial drugs.

Functional analysis of drug resistance in Plasmodium falciparum in the post-genomic era.

Potentiation of the antimalarial agent rufigallol.

Potentiation of an antimalarial oxidant drug.

P304

144-150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.46.1.144-150.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11751125

http://www.w3.org/2001/XMLSchema#string

P921

P932

126978

http://www.w3.org/2001/XMLSchema#string